DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,126 filers reported holding DANAHER CORPORATION in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $134,567,000 | -45.5% | 1,568,751 | -46.4% | 0.30% | -49.2% |
| Q2 2017 | $246,892,000 | +10.0% | 2,925,603 | +11.5% | 0.59% | +6.9% |
| Q1 2017 | $224,392,000 | -8.7% | 2,623,552 | -16.9% | 0.55% | -11.2% |
| Q4 2016 | $245,748,000 | +28.0% | 3,157,097 | +28.9% | 0.62% | +28.7% |
| Q3 2016 | $192,059,000 | -18.2% | 2,450,049 | +5.4% | 0.48% | -18.9% |
| Q2 2016 | $234,809,000 | -38.0% | 2,324,840 | -41.8% | 0.60% | -37.9% |
| Q1 2016 | $378,934,000 | +32.0% | 3,994,671 | +29.2% | 0.96% | +34.1% |
| Q4 2015 | $287,107,000 | +18.8% | 3,091,159 | +9.0% | 0.72% | +17.9% |
| Q3 2015 | $241,722,000 | +9.2% | 2,836,774 | +9.7% | 0.61% | +15.6% |
| Q2 2015 | $221,277,000 | – | 2,585,316 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |